Literature DB >> 22328665

Escherichia coli serotype O55:H7 diversity supports parallel acquisition of bacteriophage at Shiga toxin phage insertion sites during evolution of the O157:H7 lineage.

Jennifer L Kyle1, Craig A Cummings, Craig T Parker, Beatriz Quiñones, Paolo Vatta, Elizabeth Newton, Steven Huynh, Michelle Swimley, Lovorka Degoricija, Melissa Barker, Samar Fontanoz, Kimberly Nguyen, Ronak Patel, Rixun Fang, Robert Tebbs, Olga Petrauskene, Manohar Furtado, Robert E Mandrell.   

Abstract

Enteropathogenic Escherichia coli (EPEC) continues to be a leading cause of mortality and morbidity in children around the world. Two EPEC genomes have been fully sequenced: those of EPEC O127:H6 strain E2348/69 (United Kingdom, 1969) and EPEC O55:H7 strain CB9615 (Germany, 2003). The O55:H7 serotype is a recent precursor to the virulent enterohemorrhagic E. coli O157:H7. To explore the diversity of O55:H7 and better understand the clonal evolution of O157:H7, we fully sequenced EPEC O55:H7 strain RM12579 (California, 1974), which was collected 1 year before the first U.S. isolate of O157:H7 was identified in California. Phage-related sequences accounted for nearly all differences between the two O55:H7 strains. Additionally, O55:H7 and O157:H7 strains were tested for the presence and insertion sites of Shiga toxin gene (stx)-containing bacteriophages. Analysis of non-phage-associated genes supported core elements of previous O157:H7 stepwise evolutionary models, whereas phage composition and insertion analyses suggested a key refinement. Specifically, the placement and presence of lambda-like bacteriophages (including those containing stx) should not be considered stable evolutionary markers or be required in placing O55:H7 and O157:H7 strains within the stepwise evolutionary models. Additionally, we suggest that a 10.9-kb region (block 172) previously believed unique to O55:H7 strains can be used to identify early O157:H7 strains. Finally, we defined two subsets of O55:H7 strains that share an as-yet-unobserved or extinct common ancestor with O157:H7 strains. Exploration of O55:H7 diversity improved our understanding of the evolution of E. coli O157:H7 and suggested a key revision to accommodate existing and future configurations of stx-containing bacteriophages into current models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328665      PMCID: PMC3318487          DOI: 10.1128/JB.00120-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  77 in total

Review 1.  Lateral gene transfer and the nature of bacterial innovation.

Authors:  H Ochman; J G Lawrence; E A Groisman
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein.

Authors:  Kristina Creuzburg; Jürgen Recktenwald; Volker Kuhle; Sylvia Herold; Michael Hensel; Herbert Schmidt
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

3.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

4.  Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes.

Authors:  Peter C H Feng; Karen Jinneman; Flemming Scheutz; Steven R Monday
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

5.  Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7.

Authors:  P Feng; K A Lampel; H Karch; T S Whittam
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

6.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

7.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Nucleotide sequence of the integration site of the temperate bacteriophage 6220, which carries the Shiga toxin gene stx(1ox3).

Authors:  Claudia Koch; Stefan Hertwig; Bernd Appel
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

9.  Molecular archaeology of the Escherichia coli genome.

Authors:  J G Lawrence; H Ochman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model.

Authors:  Peter C H Feng; Steven R Monday; David W Lacher; Lesley Allison; Anja Siitonen; Christine Keys; Marjut Eklund; Hideki Nagano; Helge Karch; James Keen; Thomas S Whittam
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

View more
  33 in total

1.  Characterization of the pathogenome and phylogenomic classification of enteropathogenic Escherichia coli of the O157:non-H7 serotypes.

Authors:  Fatemeh Sanjar; Brigida Rusconi; Tracy H Hazen; Sara S K Koenig; Mark K Mammel; Peter C H Feng; David A Rasko; Mark Eppinger
Journal:  Pathog Dis       Date:  2015-05-10       Impact factor: 3.166

2.  Characterization of a P1-like bacteriophage carrying an SHV-2 extended-spectrum β-lactamase from an Escherichia coli strain.

Authors:  Typhaine Billard-Pomares; Stéphanie Fouteau; Marie Elise Jacquet; David Roche; Valérie Barbe; Miguel Castellanos; Jean Yves Bouet; Stéphane Cruveiller; Claudine Médigue; Jorge Blanco; Olivier Clermont; Erick Denamur; Catherine Branger
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

3.  The evolutionary divergence of Shiga toxin-producing Escherichia coli is reflected in clustered regularly interspaced short palindromic repeat (CRISPR) spacer composition.

Authors:  Shuang Yin; Mark A Jensen; Jiawei Bai; Chitrita Debroy; Rodolphe Barrangou; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2013-07-12       Impact factor: 4.792

4.  Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli.

Authors:  Tracy H Hazen; Jason W Sahl; Claire M Fraser; Michael S Donnenberg; Flemming Scheutz; David A Rasko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 5.  Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection.

Authors:  Nathan K Ho; Aleah C Henry; Kathene Johnson-Henry; Philip M Sherman
Journal:  Can J Gastroenterol       Date:  2013       Impact factor: 3.522

6.  Identification and characterization of spontaneous deletions within the Sp11-Sp12 prophage region of Escherichia coli O157:H7 Sakai.

Authors:  Chun Chen; Carrie R Lewis; Kakolie Goswami; Elisabeth L Roberts; Chitrita DebRoy; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

7.  Estimating the prevalence of potential enteropathogenic Escherichia coli and intimin gene diversity in a human community by monitoring sanitary sewage.

Authors:  Kun Yang; Eulyn Pagaling; Tao Yan
Journal:  Appl Environ Microbiol       Date:  2013-10-18       Impact factor: 4.792

Review 8.  A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses.

Authors:  Jinhee Hyun; Saravana Kanagavelu; Masayuki Fukata
Journal:  Microbes Infect       Date:  2012-10-29       Impact factor: 2.700

9.  Prophages integrating into prophages: A mechanism to accumulate type III secretion effector genes and duplicate Shiga toxin-encoding prophages in Escherichia coli.

Authors:  Keiji Nakamura; Yoshitoshi Ogura; Yasuhiro Gotoh; Tetsuya Hayashi
Journal:  PLoS Pathog       Date:  2021-04-29       Impact factor: 6.823

10.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.